The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Private job creation totaled a stunning 233,000 in October, far more than expected, ADP says
ADP said it was the best month for job creation since July 2023.
U.S. economy added just 143,000 jobs in January but unemployment rate fell to 4%
Nonfarm payrolls were projected to increase by 169,000 in January, according to the Dow Jones consensus forecast.
European deregulation push creates ‘moment of opportunity’ to boost growth
Sentiment toward the continent’s growth outlook is brightening thanks to promises of fewer shackles on business.